Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v3.21.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 41 $ 30,386 $ 101,921,707 $ 134,331 $ (93,150,198) $ 8,936,267
Balance (in shares) at Dec. 31, 2018 4,092 3,038,592        
Stock-Based Compensation     852,230     852,230
Issuance of Common Stock in Offerings, Net of Offering Costs   $ 6,000 1,771,918     1,777,918
Issuance of Common Stock in Offerings, Net of Offering Costs (in shares)   600,000        
Issuance of Shares of Common Stock from Warrant Exercises   $ 4,480 2,145,736     2,150,216
Issuance of Shares of Common Stock from Warrant Exercises (in shares)   447,961        
Dissolution of Foreign Entity           0
Issuance of Common Stock from Restricted Stock Award Grants (in shares)   (23)        
Cancellation of Fractional Shares due to Reverse Stock Split (Shares)   (23)        
Settlement of Fractional Shares due to Reverse Stock Split   $ (9) (2,605)     (2,614)
Settlement of Fractional Shares due to Reverse Stock Split (in shares)   (907)        
Cancellation of Restricted Stock   $ (79) 79     0
Cancellation of Restricted Stock (in shares)   (7,868)        
Foreign Currency Translation Adjustment       5,134   5,134
Net Loss         (7,096,696) (7,096,696)
Balance at Dec. 31, 2019 $ 41 $ 40,778 106,689,065 139,465 (100,246,894) 6,622,455
Balance (in shares) at Dec. 31, 2019 4,092 4,077,755        
Stock-Based Compensation     723,856     723,856
Issuance of Common Stock in Offerings, Net of Offering Costs   $ 5,000 4,496,313     4,501,313
Issuance of Common Stock in Offerings, Net of Offering Costs (in shares)   500,000        
Issuance of Shares of Common Stock from Warrant Exercises   $ 454 217,546     218,000
Issuance of Shares of Common Stock from Warrant Exercises (in shares)   45,417        
Shares Issued to Panoptes Stockholders at Acquisition   $ 8,842 3,157,282     3,166,124
Shares Issued to Panoptes Stockholders at Acquisition (in shares) 46 (884,222)        
Dissolution of Foreign Entity       (113,717)   (113,717)
Issuance of Common Stock from Restricted Stock Award Grants   $ 490 (490)      
Issuance of Common Stock from Restricted Stock Award Grants (in shares)   49,000        
Cancellation of Fractional Shares due to Reverse Stock Split   $ (490) 490      
Cancellation of Fractional Shares due to Reverse Stock Split (Shares)   49,000        
Cancellation of Restricted Stock           490
Foreign Currency Translation Adjustment       (26,550)   (26,550)
Net Loss         (8,091,940) (8,091,940)
Balance at Dec. 31, 2020 $ 41 $ 55,564 $ 115,283,572 $ (802) $ (108,338,834) $ 6,999,541
Balance (in shares) at Dec. 31, 2020 4,138 5,556,394